Safety and immunogenicity of hydrogen peroxide-inactivated pertussis toxoid in 18-month-old children (Q34642226)

3 August 2017

Safety and immunogenicity of hydrogen peroxide-inactivated pertussis toxoid in 18-month-old children (English)

1 reference

3 August 2017

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

17 November 2022

author name string

G. R. Siber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759491

17 November 2022

N. Thakrar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759491

17 November 2022

B. A. Yancey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759491

17 November 2022

L. Herzog

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759491

17 November 2022

C. Todd

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759491

17 November 2022

N. Cohen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759491

17 November 2022

R. D. Sekura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759491

17 November 2022

C. U. Lowe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759491

17 November 2022

language of work or name

English

0 references

publication date

1 October 1991

1 reference

full work available at URL

3 August 2017

https://api.elsevier.com/content/article/PII:0264410X9190289I?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

https://api.elsevier.com/content/article/PII:0264410X9190289I?httpAccept=text/plain

17 November 2022

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

17 November 2022

1 reference

3 August 2017

9

1 reference

3 August 2017

10

1 reference

3 August 2017

735-740

1 reference

The efficacy of acellular pertussis vaccine

3 August 2017

3

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial

17 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

Pertussis vaccine: present status and future prospects

17 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis

17 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

Acellular pertussis vaccines: evaluation of reversion in a nude mouse model

17 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

Clinical, metabolic, and antibody responses of adult volunteers to an investigational vaccine composed of pertussis toxin inactivated by hydrogen peroxide

17 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

Mutants of pertussis toxin suitable for vaccine development

17 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies

17 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells.

17 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

Evaluation of a new highly purified pertussis vaccine in infants and children

17 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

Acellular pertussis vaccine in adults: adverse reactions and immune response

17 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

Adverse reactions and antibody responses to acellular pertussis vaccine

17 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

Metabolic and hematologic effects and immune complex formation related to pertussis immunization

17 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis

17 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old children

17 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90289-I

17 November 2022

Identifiers

1 reference

3 August 2017

1 reference